Friday, 6 November 2026European Markets

Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low

The euro appreciated 14% in 2025 while the U.S. Dollar Index tumbled 10.8% in early 2026, driving major currency realignment across European markets. The British pound fell 0.4% to €1.13—its lowest level since April 2023—despite gaining 7% against the dollar in 2025, as analysts warn of further pressure toward $1.30.

LM Salvado
LM Salvado

March 17, 2026

Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The euro gained 14% against the dollar in 2025, marking a significant shift in European currency dynamics as the U.S. Dollar Index dropped 10.8% in early 2026.1 The broad-based dollar weakness has created divergent outcomes for European currencies, with the British pound facing renewed pressure despite earlier strength.

Sterling fell 0.4% to €1.13 in late November 2026, reaching its lowest level against the euro since April 2023.2 The pound also declined 0.5% to $1.3086, hovering near the $1.30 threshold that analysts view as a critical support level.2 Simon Phillips, managing director at No1 Currency, noted the pound remains under pressure amid broader market uncertainty.2

The currency realignment reflects shifting monetary policy expectations, particularly with Federal Reserve leadership transition scheduled for June 2026. Jordan Rochester, analyst at Mizuho Bank, warned the pound could fall below $1.30 as market conditions evolve.2

The British pound had gained 7% against the dollar in 2025, but that momentum reversed in early 2026 as dollar weakness failed to provide sustained support.1 The euro's strength has outpaced sterling gains, creating pressure on UK export competitiveness and cross-border trade dynamics.

Currency volatility has increased across emerging markets as well. The Turkish lira weakened 17% amid a carry trade collapse, while the Swiss franc strengthened as investors sought safe-haven assets.1 These moves highlight the systemic nature of the current currency realignment, with the franc serving as a hedge against broader market instability.

European equity markets showed resilience despite currency turbulence. The Stoxx 600 climbed 0.6% to a record 583.4 points, while Germany's DAX gained 0.9% and France's CAC 40 rose 0.7%.2 The FTSE 100 reached a record high of 9,911, though sterling weakness complicated the outlook for UK importers.2

The dollar's decline has created opportunities for European exporters but challenges for companies with dollar-denominated debt. Market participants are closely watching Fed policy signals as the June 2026 leadership transition approaches, with currency markets pricing in continued volatility through mid-year.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 7, 2026
    Ray Dalio says America is facing a ‘debt death spiral’ — but you can protect your portfolio with these 3 assets
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com